Tarsus Pharmaceuticals, Inc. earnings per share and revenue

TARS earnings per share for the last quarter are -0.60 USD whereas the estimation was -0.74 USD which accounts for 19.25% surprise. Company revenue for the same period amounts to 66.41 M USD despite the estimated figure of 58.80 M USD. Estimated earnings per share for the next quarter are -0.79 USD, and revenue is expected to reach 68.97 M USD. Also watch annual changes over time to get a bigger picture of TARS earnings per share and revenue dynamics.